Development of intranasal implantable devices for schizophrenia treatment.
Utomo E, Domínguez-Robles J, Moreno-Castellanos N, Stewart SA, Picco CJ, Anjani QK, Simón JA, Peñuelas I, Donnelly RF, Larrañeta E.
Utomo E, et al.
Int J Pharm. 2022 Aug 25;624:122061. doi: 10.1016/j.ijpharm.2022.122061. Epub 2022 Jul 28.
Int J Pharm. 2022.
PMID: 35908633
Free article.